arrow
S

Stephen Qi Rong Wong

houston methodist research institute
H指数:5
被引数:71

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial

曲美木单抗联合或不联合度伐利尤单抗,与紫杉醇联用治疗转移性尿路上皮癌:ICRA I/II期临床试验

2026-06-170
OAAI
Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype

构建奥沙利铂耐药的结直肠癌模型揭示了基于SERPINE1的基因签名(RESIST-M)及促进转移的CMS4亚型的治疗策略

2025-07-160
OAAI
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC) (vol 64, 103220, 2021)
2021-04-010
OAAI
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
2021-02-0113
OAAI